cgp 35348 has been researched along with cgp 46381 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumann, PA; Bernasconi, R; Diel, PJ; Froestl, W; Hall, RG; Maier, L; Melillo, V; Mickel, SJ; Strub, D; von Sprecher, G | 1 |
| Bickford, PC; Freedman, R; Hershman, KM | 1 |
| Curtis, DR; Lacey, G | 1 |
| Aizawa, M; Fukuda, H; Ito, Y | 1 |
| Fukuda, H; Ishige, K; Ito, Y | 1 |
5 other study(ies) available for cgp 35348 and cgp 46381
| Article | Year |
|---|---|
Phosphinic acid analogues of GABA. 2. Selective, orally active GABAB antagonists.
Topics: Administration, Oral; Amnesia; Animals; Cerebral Cortex; GABA-B Receptor Antagonists; gamma-Aminobutyric Acid; Hippocampus; In Vitro Techniques; Learning; Long-Term Potentiation; Magnetic Resonance Spectroscopy; Phosphinic Acids; Protein Binding; Radioligand Assay; Rats; Receptors, GABA-B; Structure-Activity Relationship | 1995 |
GABAB antagonists diminish the inhibitory gating of auditory response in the rat hippocampus.
Topics: Acoustic Stimulation; Animals; Auditory Pathways; Auditory Perception; GABA Antagonists; GABA-B Receptor Antagonists; Hippocampus; Injections, Intraventricular; Organophosphorus Compounds; Phosphinic Acids; Pyramidal Cells; Rats | 1995 |
GABA-B receptor-mediated spinal inhibition.
Topics: Afferent Pathways; Animals; Baclofen; Bicuculline; Cats; Decerebrate State; Depression, Chemical; GABA Antagonists; gamma-Aminobutyric Acid; Organophosphorus Compounds; Phosphinic Acids; Receptors, GABA; Reflex, Monosynaptic; Spinal Cord; Tetany | 1994 |
Pharmacological profiles of generalized absence seizures in lethargic, stargazer and gamma-hydroxybutyrate-treated model mice.
Topics: Animals; Disease Models, Animal; Dizocilpine Maleate; Electroencephalography; Epilepsy, Generalized; Female; GABA Antagonists; Male; Mice; Mice, Neurologic Mutants; Organophosphorus Compounds; Phosphinic Acids; Sodium Oxybate | 1997 |
Pharmacological profiles of absence seizure-induced increases in CRE- and AP-1 DNA-binding activities in gamma-butyrolactone-treated mice.
Topics: 4-Butyrolactone; Activating Transcription Factor 2; Animals; Anticonvulsants; Brain; Brain Chemistry; Cerebral Cortex; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; DNA-Binding Proteins; Epilepsy, Absence; Ethosuximide; GABA Antagonists; Mice; Organophosphorus Compounds; Phosphinic Acids; Thalamus; Transcription Factor AP-1; Transcription Factors | 1998 |